Novel oral glucose‐lowering drugs are associated with lower risk of all‐cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type...

por Nyström, Thomas, Bodegard, Johan, Nathanson, David, Thuresson, Marcus, Norhammar, Anna, Eriksson, Jan W.
Publicado 2017

Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE‐TIMI 58 trial: A nationwide observational study...

por Norhammar, Anna, Bodegård, Johan, Nyström, Thomas, Thuresson, Marcus, Nathanson, David, Eriksson, Jan W.
Publicado 2019

Cross-sectional and longitudinal analyses of the association between lung function and exercise capacity in healthy Norwegian men

por Farkhooy, Amir, Bodegård, Johan, Erikssen, Jan Erik, Janson, Christer, Hedenström, Hans, Stavem, Knut, Malinovschi, Andrei
Publicado 2018

Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006–2014

por Nathanson, David, Sabale, Ugne, Eriksson, Jan W., Nyström, Thomas, Norhammar, Anna, Olsson, Urban, Bodegård, Johan
Publicado 2017

Dapagliflozin vs non‐SGLT‐2i treatment is associated with lower healthcare costs in type 2 diabetes patients similar to participants in the DECLARE‐TIMI 58 trial: A nationwide obse...

por Norhammar, Anna, Bodegard, Johan, Nyström, Thomas, Thuresson, Marcus, Rikner, Klas, Nathanson, David, Eriksson, Jan W.
Publicado 2019

History of heart failure and chronic kidney disease and risk of all-cause death after COVID-19 during the first three waves of the pandemic in comparison with influenza outbreaks i...

por Ritsinger, Viveca, Bodegård, Johan, Kristofi, Robin, Thuresson, Marcus, Nathanson, David, Nyström, Thomas, Eriksson, Jan, Norhammar, Anna
Publicado 2023

Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study

por Grundvold, Irene, Bodegard, Johan, Nilsson, Peter M, Svennblad, Bodil, Johansson, Gunnar, Östgren, Carl Johan, Sundström, Johan
Publicado 2015

Sodium–glucose cotransporter 2 inhibitors compared with other glucose‐lowering drugs in Japan: Subanalyses of the CVD‐REAL 2 Study

por Kohsaka, Shun, Takeda, Masayoshi, Bodegård, Johan, Thuresson, Marcus, Kosiborod, Mikhail, Yajima, Toshitaka, Wittbrodt, Eric, Fenici, Peter
Publicado 2020

Association Between Paradoxical HDL Cholesterol Decrease and Risk of Major Adverse Cardiovascular Events in Patients Initiated on Statin Treatment in a Primary Care Setting

por Hasvold, Pål, Thuresson, Marcus, Sundström, Johan, Hammar, Niklas, Kjeldsen, Sverre E., Johansson, Gunnar, Holme, Ingar, Bodegård, Johan
Publicado 2015

Patients with type 1 and type 2 diabetes hospitalized with COVID-19 in comparison with influenza: mortality and cardiorenal complications assessed by nationwide Swedish registry da...

por Kristófi, Robin, Bodegard, Johan, Ritsinger, Viveca, Thuresson, Marcus, Nathanson, David, Nyström, Thomas, Norhammar, Anna, Eriksson, Jan W.
Publicado 2022

Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study

por Kristófi, Robin, Bodegard, Johan, Norhammar, Anna, Thuresson, Marcus, Nathanson, David, Nyström, Thomas, Birkeland, Kåre I., Eriksson, Jan W.
Publicado 2021

Impact of ischaemic heart disease severity and age on risk of cardiovascular outcome in diabetes patients in Sweden: a nationwide observational study

por Jernberg, Tomas, Lindholm, Daniel, Hasvold, Lars Pål, Svennblad, Bodil, Bodegård, Johan, Sundell Andersson, Karolina, Thuresson, Marcus, Erlinge, David, Janzon, Magnus
Publicado 2019

Temporal Reduction in Chronotropic Index Predicts Risk of Cardiovascular Death Among Healthy Middle‐Aged Men: a 28‐Year Follow‐Up Study

por Engeseth, Kristian, Hodnesdal, Christian, Grundvold, Irene, Liestøl, Knut, Gjesdal, Knut, Kjeldsen, Sverre E., Erikssen, Jan E., Bodegard, Johan, Skretteberg, Per Torger
Publicado 2016

How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study

por Birkeland, Kåre I., Bodegard, Johan, Norhammar, Anna, Kuiper, Josephina G., Georgiado, Elena, Beekman‐Hendriks, Wendy L., Thuresson, Marcus, Pignot, Marc, Herings, Ron M. C., Kooy, Adriaan
Publicado 2019

Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults

por Schechter, Meir, Melzer Cohen, Cheli, Yanuv, Ilan, Rozenberg, Aliza, Chodick, Gabriel, Bodegård, Johan, Leiter, Lawrence A., Verma, Subodh, Lambers Heerspink, Hiddo J., Karasik, Avraham, Mosenzon, Ofri
Publicado 2022

Dapagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in people with type 2 diabetes (CVD‐REAL Nordic) when compared with dipeptidyl peptidas...

por Persson, Frederik, Nyström, Thomas, Jørgensen, Marit E., Carstensen, Bendix, Gulseth, Hanne L., Thuresson, Marcus, Fenici, Peter, Nathanson, David, Eriksson, Jan W., Norhammar, Anna, Bodegard, Johan, Birkeland, Kåre I.
Publicado 2017

Prevalence, outcomes and costs of a contemporary, multinational population with heart failure

por Norhammar, Anna, Bodegard, Johan, Vanderheyden, Marc, Tangri, Navdeep, Karasik, Avraham, Maggioni, Aldo Pietro, Sveen, Kari Anne, Taveira-Gomes, Tiago, Botana, Manuel, Hunziker, Lukas, Thuresson, Marcus, Banerjee, Amitava, Sundström, Johan, Bollmann, Andreas
Publicado 2023

Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effect...

por Kosiborod, Mikhail, Cavender, Matthew A., Fu, Alex Z., Wilding, John P., Khunti, Kamlesh, Holl, Reinhard W., Norhammar, Anna, Birkeland, Kåre I., Jørgensen, Marit Eika, Thuresson, Marcus, Arya, Niki, Bodegård, Johan, Hammar, Niklas, Fenici, Peter
Publicado 2017

Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2‐inhibitors versus other glucose‐lowering agents in real‐world clinical practice: Results from...

por Kosiborod, Mikhail, Birkeland, Kåre I., Cavender, Matthew A., Fu, Alex Z., Wilding, John P., Khunti, Kamlesh, Holl, Reinhard W., Norhammar, Anna, Jørgensen, Marit E., Wittbrodt, Eric T., Thuresson, Marcus, Bodegård, Johan, Hammar, Niklas, Fenici, Peter
Publicado 2018

Different patterns of second‐line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study...

por Persson, Frederik, Bodegard, Johan, Lahtela, Jorma T., Nyström, Thomas, Jørgensen, Marit E., Jensen, Majken Linneman, Gulseth, Hanne L., Thuresson, Marcus, Hoti, Fabian, Nathanson, David, Norhammar, Anna, Birkeland, Kåre I., Eriksson, Johan G., Eriksson, Jan W.
Publicado 2018